537 related articles for article (PubMed ID: 11292637)
1. Leishmaniasis: current status of vaccine development.
Handman E
Clin Microbiol Rev; 2001 Apr; 14(2):229-43. PubMed ID: 11292637
[TBL] [Abstract][Full Text] [Related]
2. Recombinant DNA-derived leishmania proteins: from the laboratory to the field.
Kubar J; Fragaki K
Lancet Infect Dis; 2005 Feb; 5(2):107-14. PubMed ID: 15680780
[TBL] [Abstract][Full Text] [Related]
3. Second-generation vaccines against leishmaniasis.
Coler RN; Reed SG
Trends Parasitol; 2005 May; 21(5):244-9. PubMed ID: 15837614
[TBL] [Abstract][Full Text] [Related]
4. Live attenuated Leishmania vaccines: a potential strategic alternative.
Silvestre R; Cordeiro-da-Silva A; Ouaissi A
Arch Immunol Ther Exp (Warsz); 2008; 56(2):123-6. PubMed ID: 18373245
[TBL] [Abstract][Full Text] [Related]
5. The immunology of Leishmania infection and the implications for vaccine development.
Vanloubbeeck Y; Jones DE
Ann N Y Acad Sci; 2004 Oct; 1026():267-72. PubMed ID: 15604504
[TBL] [Abstract][Full Text] [Related]
6. Genetically modified live attenuated parasites as vaccines for leishmaniasis.
Selvapandiyan A; Duncan R; Debrabant A; Lee N; Sreenivas G; Salotra P; Nakhasi HL
Indian J Med Res; 2006 Mar; 123(3):455-66. PubMed ID: 16778323
[TBL] [Abstract][Full Text] [Related]
7. [Approaches and problems in vaccine development against leishmaniasis].
Allahverdiyev A; Bağirova M; Cakir Koç R; Oztel ON; Elçıçek S; Ateş SC; Karaca TD
Turkiye Parazitol Derg; 2010; 34(2):122-30. PubMed ID: 20597059
[TBL] [Abstract][Full Text] [Related]
8. Progress towards a Leishmania vaccine.
Tabbara KS
Saudi Med J; 2006 Jul; 27(7):942-50. PubMed ID: 16830009
[TBL] [Abstract][Full Text] [Related]
9. Vaccine candidates for leishmaniasis: a review.
Nagill R; Kaur S
Int Immunopharmacol; 2011 Oct; 11(10):1464-88. PubMed ID: 21616175
[TBL] [Abstract][Full Text] [Related]
10. Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era.
Dumonteil E
Infect Genet Evol; 2009 Dec; 9(6):1075-82. PubMed ID: 19805015
[TBL] [Abstract][Full Text] [Related]
11. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
Ahmed SB; Touihri L; Chtourou Y; Dellagi K; Bahloul C
Vaccine; 2009 Jan; 27(1):99-106. PubMed ID: 18951941
[TBL] [Abstract][Full Text] [Related]
12. Possibilities and challenges for developing a successful vaccine for leishmaniasis.
Srivastava S; Shankar P; Mishra J; Singh S
Parasit Vectors; 2016 May; 9(1):277. PubMed ID: 27175732
[TBL] [Abstract][Full Text] [Related]
13. Leishmania vaccines: progress and problems.
Kedzierski L; Zhu Y; Handman E
Parasitology; 2006; 133 Suppl():S87-112. PubMed ID: 17274851
[TBL] [Abstract][Full Text] [Related]
14. Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis.
Duarte MC; Lage DP; Martins VT; Chávez-Fumagalli MA; Roatt BM; Menezes-Souza D; Goulart LR; Soto M; Tavares CA; Coelho EA
Rev Soc Bras Med Trop; 2016; 49(4):398-407. PubMed ID: 27598624
[TBL] [Abstract][Full Text] [Related]
15. Present status of antileishmanial vaccines.
Ghosh M; Bandyopadhyay S
Mol Cell Biochem; 2003 Nov; 253(1-2):199-205. PubMed ID: 14619970
[TBL] [Abstract][Full Text] [Related]
16. Leishmania Vaccines: the Current Situation with Its Promising Aspect for the Future.
Dinc R
Korean J Parasitol; 2022 Dec; 60(6):379-391. PubMed ID: 36588414
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in vaccines for leishmaniasis.
Requena JM; Iborra S; Carrión J; Alonso C; Soto M
Expert Opin Biol Ther; 2004 Sep; 4(9):1505-17. PubMed ID: 15335317
[TBL] [Abstract][Full Text] [Related]
18. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
[TBL] [Abstract][Full Text] [Related]
19. Leishmaniasis.
Kedzierski L
Hum Vaccin; 2011 Nov; 7(11):1204-14. PubMed ID: 22048116
[TBL] [Abstract][Full Text] [Related]
20. Development of a leishmaniasis vaccine: the importance of MPL.
Reed SG; Coler RN; Campos-Neto A
Expert Rev Vaccines; 2003 Apr; 2(2):239-52. PubMed ID: 12899575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
